跳至主要内容
临床试验/NCT03383861
NCT03383861终止不适用

Nutrition Status, Bone Mass Density, and Selective Serotonin Reuptake Inhibitors

University of New Mexico0 个研究点目标入组 13,027 人开始时间: 2005年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
13,027
主要终点
BMD t-score

研究概览

简要总结

The association between selective serotonin reuptake inhibitor (SSRI) use and bone mass density (BMD) has been debated. Some have suggested features of depression, which SSRIs are prescribed to treat, may be a cause of decreased BMD, such as poor overall food intake at the time of SSRI use. Our study seeks to determine whether SSRI use in adults is associated with lower than average BMD, and if there is an association between low micronutrient intake, SSRI use, and a low BMD.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Included adult NHANES participants are those who participated in the Dual-Energy X-ray Absorptiometry (DXA) femur-neck BMD test and responded in full to the demographic, pharmaceutical, and dietary surveys.

排除标准

  • Pregnancy, incomplete survey responses, incomplete DXA results

结局指标

主要结局

BMD t-score

时间窗: NHANES DXA measurement taken 2005-2014

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Nutrition Status, BMD, and SSRIs | 临床试验